Cargando…

ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease

ASPP2 is a pro-apoptotic member of the p53 binding protein family. ASPP2 has been shown to inhibit autophagy, which maintains energy balance in nutritional deprivation. We attempted to identify the role of ASPP2 in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). In a NAFLD cell model,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Fang, Jia, Lin, Lin, Minghua, Shi, Ying, Yin, Jiming, Liu, Yin, Chen, Dexi, Meng, Qinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288359/ https://www.ncbi.nlm.nih.gov/pubmed/25256142 http://dx.doi.org/10.1111/jcmm.12364

Ejemplares similares

ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy
por: Lin, Minghua, et al.
Publicado: (2017)

ASPP2 Coordinates ERS-Mediated Autophagy and Apoptosis Through mTORC1 Pathway in Hepatocyte Injury Induced by TNF-α
por: Yao, Jia, et al.
Publicado: (2022)

ASPP2 Plays a Dual Role in gp120-Induced Autophagy and Apoptosis of Neuroblastoma Cells
por: Liu, Zhiying, et al.
Publicado: (2017)

Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice
por: Wang, Shanshan, et al.
Publicado: (2021)

Exogenous p53 and ASPP2 expression enhances rAdV-TK/GCV-induced death in hepatocellular carcinoma cells lacking functional p53
por: Liu, Xiuhong, et al.
Publicado: (2016)

Overexpression of iASPP is required for autophagy in response to oxidative stress in choriocarcinoma
por: Chan, Ka-Kui, et al.
Publicado: (2019)

ASPP2 inhibits hepatitis B virus replication by preventing nucleus translocation of HSF1 and attenuating the transactivation of ATG7
por: Wang, Shanshan, et al.
Publicado: (2021)

EGR-1/ASPP1 inter-regulatory loop promotes apoptosis by inhibiting cyto-protective autophagy
por: Zhao, Kunming, et al.
Publicado: (2017)

ASPP2 enhances Oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy
por: Shi, Ying, et al.
Publicado: (2015)

ASPP2 promotes cell apoptosis in cervical cancer through inhibiting autophagy
por: Jiang, Feiyun, et al.
Publicado: (2022)

Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice
por: Xie, Fang, et al.
Publicado: (2022)

Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease
por: Zhang, Yizhi, et al.
Publicado: (2022)

Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax
por: Patel, Seema, et al.
Publicado: (2008)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

iASPP facilitates tumor growth by promoting mTOR-dependent autophagy in human non-small-cell lung cancer
por: Xue, Yijun, et al.
Publicado: (2017)

Triglyceride-derived fatty acids reduce autophagy in a model of retinal angiomatous proliferation
por: Heckel, Emilie, et al.
Publicado: (2022)

The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
por: Dong, Yuan, et al.
Publicado: (2022)

Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease
por: Jia, Lin, et al.
Publicado: (2018)

ASPP2 involvement in p53-mediated HIV-1 envelope glycoprotein gp120 neurotoxicity in mice cerebrocortical neurons
por: Liu, Zhiying, et al.
Publicado: (2016)

Nucleostemin and ASPP2 expression is correlated with pituitary adenoma proliferation
por: MA, LIN, et al.
Publicado: (2013)

Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation
por: Song, Bin, et al.
Publicado: (2015)

LncRP11-675F6.3 responds to rapamycin treatment and reduces triglyceride accumulation via interacting with HK1 in hepatocytes by regulating autophagy and VLDL-related proteins: LncRNA with HK1 regulates triglycerides, autophagy and VLDL
por: Wang, Lingling, et al.
Publicado: (2023)

Protocol for measuring intrahepatic triglyceride content in adults with non-alcohol fatty liver disease
por: Ezpeleta, Mark, et al.
Publicado: (2023)

Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2015)

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells
por: Wang, Y, et al.
Publicado: (2013)

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
por: Kawano, Yuki, et al.
Publicado: (2013)

Autophagy protects against palmitate-induced apoptosis in hepatocytes
por: Cai, Ning, et al.
Publicado: (2014)

Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease
por: Lakhani, Hari Vishal, et al.
Publicado: (2018)

LSDP5 Enhances Triglyceride Storage in Hepatocytes by Influencing Lipolysis and Fatty Acid β-Oxidation of Lipid Droplets
por: Li, Hang, et al.
Publicado: (2012)

Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation
por: Chen, Rui, et al.
Publicado: (2016)

Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP
por: Liu, Xiangrong, et al.
Publicado: (2018)

SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity
por: Zhang, Tian, et al.
Publicado: (2019)

ASPP: a new family of oncogenes and tumour suppressor genes
por: Sullivan, A, et al.
Publicado: (2007)

Nuclear iASPP may facilitate prostate cancer progression
por: Morris, E V, et al.
Publicado: (2014)

ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold
por: Posada, Itziar M. D., et al.
Publicado: (2016)

Regulation of immunological tolerance by the p53-inhibitor iASPP
por: Akama-Garren, Elliot H., et al.
Publicado: (2023)

iASPP regulates neurite development by interacting with Spectrin proteins
por: Wang, Junhao, et al.
Publicado: (2023)

Lipocalin‐2 Protects Against Diet‐Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes
por: Xu, Yanyong, et al.
Publicado: (2019)

Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease
por: Pang, Lijun, et al.
Publicado: (2018)

Hyaluronan-Induced CD44-iASPP Interaction Affects Fibroblast Migration and Survival
por: Lin, Chun-Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vu5magaaq4a2j2apa3nfcdpcg1